A former pharmacy tech at Mercy Hospital in Springfield, Mo., was sentenced to three years in prison last week for stealing painkillers, according to The Springfield News-Leader.

Pfizer received FDA approval May 6 for Vyndaqel, which treats a rare and fatal heart disease. The drug will launch with a list price of $225,000 per year in the U.S., according to Reuters.

A federal judge has denied Aetna's bid to derail a whistleblower suit against CVS Caremark that alleges the pharmacy benefit manager overbilled Medicare by more than $1 billion for prescription drugs, according to The Columbus Dispatch.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leadership  in the last week.

Relative to nationwide averages for the cost of the 500 most commonly prescribed medications, Atlanta is the least expensive city to purchase those drugs, according  according to GoodRx's inaugural quarterly report, an in-depth analysis of drug prices and fill rates…

McKesson has agreed to pay $37 million to resolve a lawsuit in West Virginia accusing the drug distributor of contributing to the opioid crisis.

An HHS plan to force prescription drug prices down by removing rebates in the Medicare Part D program would actually have the opposite effect and hike federal spending on the program by $177 billion over 10 years, according to a…

Insys Therapeutics founder John Kapoor and four other executives were convicted May 2 of a racketeering conspiracy that boosted sales of a highly addictive opioid, helping drive the opioid crisis in the U.S., according to Reuters.

Gilead Sciences will lose its longtime CFO Robin Washington in March 2020, according to Endpoints News.

CVS Health is closing 46 stores it said are underperforming, according to Business Insider.